GLAXO: Cumple y baja precios...

Andrew Witty lo había prometido. Ahora empieza hacerse realidad...

By JEANNE WHALEN

GlaxoSmithKline Plc has started cutting prices on some of its drugs in select Asian countries, in an effort to increase its business by making products more affordable to more people, the company's chief executive said Thursday.

Glaxo in March cut prices on 28 products in the Philippines by 30% to 50% and has reduced the price of its cervical cancer vaccine in Thailand, Malaysia and other countries, Chief Executive Andrew Witty said in a telephone interview. The company is considering more cuts in other Asian markets, he said.

The price reductions are part of Glaxo's drive to build more sales in emerging markets, partly by reaching more consumers, he said. "We're ready to be flexible in our business model to be sure (Glaxo) is suited to the markets where we're working," he said.

Más...